Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Debabrata Dash has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Microbiome-mitochondria crosstalk in neuro-oncology: molecular mechanisms, immunometabolic reprogramming, and therapeutic opportunities

    by Debabrata Dash, Muskan Rajak, Priyanka Manothiya, Raj Kumar Koiri

    Although the gut microbiome is increasingly recognized as an important regulator of metabolic, immune, and neurophysiological functions, and mitochondrial dysfunction is considered a hallmark of metabolic flexibility, oxidative stress, and resistance to therapy in cancers, the role of microbiome-derived cues and mitochondrial processes in brain tumors remains poorly understood. The Microbiome-Gut-Brain-Mitochondria Axis in Neuro-Oncology provides a framework for understanding metabolism and immunity in neuro-oncology by highlighting this axis and emphasizing its role in glioblastoma. Metabolites produced by the microbiome, including short-chain fatty acids, bile acid metabolites, tryptophan metabolites, and other microbial compounds, have been shown to affect the immune system, barrier function, cellular metabolism, and neural signaling. Mitochondria are capable of functioning as intracellular communication mechanisms that will help to decipher those signals in order to create energy, ROS, calcium communication, biogenesis of mitochondria, quality control, and apoptosis. These processes may contribute to metabolic plasticity in glioblastomas, including glycolytic, oxidative phosphorylation, and amino- and lipid-metabolic adaptations, mitochondrial transfer, adaptation to hypoxia, tumor cell stemness, and immune suppression in the tumor microenvironment. The article also discusses the relationships between microbiome-derived cues, mitochondria, and tumor-associated immune populations. Microbiome-derived and mitochondrial biomarkers, combined with multi-omics approaches, single-cell technologies, spatial biology, artificial intelligence, and new experimental models, may help to identify relevant microbiome-mitochondria signatures. Modulating the microbiome, mitochondria, and combination therapies appears promising for glioblastomas. However, the causative link between microbiome-derived mitochondrial mechanisms and human brain tumors remains unproven. The necessity of prospective and mechanistic studies of the microbiome, mitochondria, metabolism, immunity, and clinical aspects arises.

  • Open Access

    Conserved and particle-specific mitochondrial stress responses drive immunotoxicity of ultrafine particulate matter, black carbon, and polystyrene nanoplastics

    by Pradyumna Kumar Mishra, Apoorva Chouksey, Aneha K. Rajan, Ashwani Pathak, Aniket Aglawe, Prakash Punj Dwivedi, Vikas Gurjar, Ravi Prakash Tiwari, Debabrata Dash, Devojit Kumar Sarma, et al.

    Introduction: Several studies have examined human exposure to ultrafine particulate matter (UFPM), Black carbon (BC), and polystyrene nanoplastics (PS-NPs). However, it remains unclear whether different chemical types of environmental nanoparticles induce a similar mitochondrial stress response or a unique particle-specific response. Methods: In the present study, we examined the molecular mechanisms underlying nanoparticle-induced mitochondrial stress response and immunotoxicity using human peripheral blood mononuclear cells exposed to UFPM, BC, and PS-NPs under similar experimental conditions. Oxidative stress, mitochondrial adaptation, respiratory chain integrity, mitochondrial integrated stress response, inflammatory signaling, and systems-level interactions between molecules were analyzed through the evaluation of the expression of NRF2, HIF-1α, PGC-1α, TFAM, OMA1, DELE1, mitochondrial ND1, Complex I-V, NF-κB, TNF-α, and NLRP3, and the use of principal component analysis, hierarchical clustering, and correlation networks. Results: All three nanoparticle exposures elicited oxidative stress and mitochondrial stress-related responses with distinct kinetics and mechanisms. UFPM mostly induced an acute antioxidant response and mitochondrial adaptation; BC led to sustained mitochondrial dysfunction and sustained induction of OMA1 and DELE1 transcripts, consistent with an OMA1-DELE1 associated mitochondrial stress response and inflammation; while PS-NPs induced low but sustained mitochondrial adaptation, along with mitochondrial biogenesis and stress responses. Based on the systems-level analysis, oxidative stress, mitochondrial adaptation, mitochondrial ISR, and inflammation appear to be highly correlated molecular pathways independent of the physicochemical properties of nanoparticles, while the coordinated expression of OMA1 and DELE1 was linked with mitochondrial stress response and inflammation, and the OMA1-DELE1 pathway might be considered as a possible regulatory module for future validation. Discussion: Overall, we found that activation of the mitochondrial stress response is a common pathway underlying the cytotoxic effects of different chemical nanoparticles. The results of the present study provide new understanding of the molecular pathways responsible for the immunotoxic effects of nanoparticles and identify OMA1, DELE1, NRF2, PGC-1α, TFAM, ND1, and Complex I-V as possible biomarkers.

  • Open Access

    Polymer-specific nanoplastics trigger oxidative stress, inflammatory activation, and mitoepigenetic remodeling: in vitro and in silico evidence for MT-ND6-mediated mitochondrial complex I perturbation

    by Pradyumna Kumar Mishra, Aneha K. Rajan, Apoorva Chouksey, Vikas Gurjar, Ashwani Pathak, Aniket Aglawe, Ravi Prakash Tiwari, Debabrata Dash, Ram Kumar Nema, Rajnarayan Tiwari, et al.

    Introduction: Recent studies have detected nanoplastics (NPs) in human tissues and biological fluids, raising concerns regarding their potential effects on cellular homeostasis. Nevertheless, their effects on mitochondrial regulation and mitoepigenetic processes remain poorly understood. This work aimed to study the polymer-specific effects of NPs, including polystyrene (PS), polypropylene (PP), and polyvinyl chloride (PVC), on mitochondrial function, mitochondrial homeostasis, oxidative stress generation, inflammatory response, and mitoepigenetics. Methods: Cell uptake of NPs was examined using flow cytometry and fluorescence microscopy. Analysis of mitochondrial membrane potential (Δψm), oxidative phosphorylation (OXPHOS), Mitochondrial reactive oxygen species (mtROS) generation, respiratory chain complexes, DNA damage repair enzymes, DNA methylation-related markers, inflammatory cytokines, and mitochondrial gene expression was performed at different time points after NP treatment. Moreover, docking analysis was performed to investigate the potential interactions between oxidized nanoplastic-derived oligomers and mitochondrial Complex I. The relationship between respiratory chain function and mtDNA expression was analyzed using regression. Results: The observed effects of the tested NPs included specific effects of each polymer type, such as increased mtROS production, reduced Δψm, induction of oxidative DNA damage, dysregulation of mitochondrial dynamics, and activation of inflammatory pathways. The stress response was characterized by downregulation of DNA methyltransferases, changes in methylation marker levels, and alterations in mitochondrial gene expression. Functional analysis identified Complex I as particularly vulnerable to the effects of NP treatment. The correlation study demonstrated the coordinated regulation of stress-response mediators in mitochondria, namely, DRP1, OMA1, DELE1, and MT-ND6. Meanwhile, the regression analysis showed a correlation between MT-ND6 expression and Complex I activity. Discussion: Collectively, these findings suggest that environmentally relevant NPs elicit polymer-dependent mitochondrial stress responses, mitoepigenetic remodeling, and inflammatory activation.


  • Open Access

    Mechanistic Insights Into Hepatotoxicity‐Induced Liver Cirrhosis and Anemia: Iron Dysregulation, the Hepcidin–Ferroportin Axis, and Emerging Therapeutic Strategies

    by Debabrata Dash, Raj Kumar Koiri

    Patients with alcohol‐associated liver cirrhosis or acetaminophen (APAP) toxicity frequently develop anemia accompanied by disturbances in iron metabolism. Dysregulation of hepcidin–ferroportin signaling, together with other factors such as inflammation, oxidative stress, hypoxia, impaired intestinal iron absorption, malnutrition, and gastrointestinal bleeding, contributes to the pathogenesis of anemia in patients with chronic liver disease. Alcohol‐ and APAP‐induced liver injury involves interconnected mechanisms, including oxidative stress, mitochondrial dysfunction, inflammation, and fibrosis. In this review, we explore the relationship between alcohol‐ and APAP‐induced hepatotoxicity, anemia, and iron dysregulation, with a focus on hepcidin‐ferroportin signaling and the regulation of hepcidin and ferroportin by inflammatory, hypoxic, erythropoietic, and iron‐dependent signals. Moreover, the development of iron deficiency and iron overload at different stages of alcoholic liver disease, as well as the roles of folate metabolism, intestinal iron absorption, the gut microbiota, erythropoietin, and erythroferrone, and the contribution of anemia‐associated hypoxia to liver injury, are discussed. Conventional treatments, including ferrous salts and folic acid, as well as emerging therapies targeting hypoxia‐inducible factor signaling, hepcidin–ferroportin signaling, intravenous iron therapy, and erythropoiesis, are discussed. The potential interaction between iron supplementation and APAP‐induced hepatotoxicity is also addressed. Finally, current knowledge gaps and promising therapeutic directions for the management of hepatotoxicity‐associated anemia are highlighted.

  • Open Access

    Synthesis, characterisation, computational study, amelioration of ruthenium kesar nanoparticle, antioxidant and glycolytic enzyme activity alterations in cirrhotic liver extract

    by Rahul Kanaoujiya, Debabrata Dash, Raj Kumar Koiri, Ghulam Mustafa, Kamalakanta Behera, Shekhar Srivastava, Shruti Trivedi, Ambrish Kumar, Amit Jaiswal, Pratima Chauhan, et al.

    Liver cirrhosis represents a progressive vascular and metabolic disease, which results due to chronic inflammatory injury to the tissues and presents with aberrant tissue regeneration, fibrosis with nodular configurations, vascular remodeling, and enhanced portal pressures along with compromised liver functions. In close correlation with the abovementioned abnormalities are defects within the mechanisms of antioxidant defense and glycolytic metabolism. The study focuses on the determination of inherent structural characteristics of ruthenium dioxide nanoparticles and determines the modulatory effects of a ruthenium complex on the activities of antioxidant and glycolytic enzymes within the cirrhotic liver samples. Structural studies proved the successful creation of a rutile RuO2 crystalline phase on a glass surface, with clear diffraction patterns pointing to a well-ordered crystal structure. FT-IR confirmed the material’s characteristic low wavenumber absorption peak in the range of 400–700 cm−1, a clear indicator of RuO2 formation. High-resolution TEM proved the presence of agglomerates of granular and faceted nanocrystals having clear boundaries, a clear indication of strong inter-particle interactions. Analysis using ImageJ confirmed a d-spacing of 9.2 Å, a clear indication of its nanocrystal nature. SLF and surface mapping studies on the bioactive ligand (safranal) proved its electrophilic nature with low binding energy and favorable hydrogen bonding (2.57 Å), a clear indication of its high molecular reactivity and biocompatibility. For bioassays, 10% homogenates of normal and cirrhotic albino rat livers were prepared in ice-cold 0.02 M Tris–Cl buffer (pH 7.4). Cytosol fractions isolated through refrigerated centrifugation were incubated with a ruthenium complex (100 mg/mL of 0.02 mM DMSO solution) for 24 h at 4 °C. The activity of antioxidant and glycolytic enzymes like lactate dehydrogenase was measured by polyacrylamide gel electrophoresis. The findings from the study show that liver cirrhosis induces significant changes in antioxidant and glycolytic enzymes; however, the treatment with the ruthenium complex was successful in modulating these changes. The study underlines the promising aspect of ruthenium nanocomplexes not only for cancer treatment but also for other diseases like liver cirrhosis.